The role of transplant in the era of new treatments for lymphoma and CLL
Side effects of novel drugs and managing patient expectations in CLL
Myeloma 2016: Panel discussion on the new treatment paradigm
Gareth Morgan et al.
How do novel agents affect allogeneic transplantation in CLL?
New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics